Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) HKSE

35.08

+6.38(+22.23%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap3.18B
Enterprise Value3.37B
P/E Ratio94.74
PEG Ratio0.36
Price/Sales Ratio10.6
Price/Book Ratio14.04
Enterprise/Revenue10.71
Enterprise/EBITDA33.36

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.22

Management Effectiveness

Return On Assets0.05
Return On Equity0.15

Income Statement

Revenue980.45M
Revenue/Share3.01
Gross Profit761.52M
EBITDA303.8M
Net Income33.54M
Diluted EPS0.08

Balance Sheet

Total Cash486.84M
Total Cash/Share1.23
Total Debt614.18M
Total Debt/Equity0.69
Current Ratio1.89
Book Value Per Share2.26

Price History

52-Week Change315.15
52-Week High35.86
52-Week Low7.07
Moving Average 50 Days28.93
Moving Average 200 Days22.06

Statistics

Average Volume534,351
Shares Outstanding399.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A